We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$53.3B
AUM Growth
+$1.63B
Cap. Flow
-$179M
Cap. Flow %
-0.34%
Top 10 Hldgs %
17.17%
Holding
3,102
New
155
Increased
2,027
Reduced
775
Closed
131

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$67.7M
2
CTVA icon
Corteva
CTVA
+$33.4M
3
TCF
TCF Financial Corporation Common Stock
TCF
+$19.3M
4
SPOT icon
Spotify
SPOT
+$15.3M
5
AMCR icon
Amcor
AMCR
+$15M

Sector Composition

Rank Sector Weight
1 Technology 18.25%
2 Financials 15.55%
3 Healthcare 13.39%
4 Consumer Discretionary 10.43%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INGR icon
526
Ingredion
INGR
$6.27B
$16.5M 0.03%
199,617
-11,240
-5% -$966K
PRAH
527
DELISTED
PRA Health Sciences, Inc.
PRAH
$16.4M 0.03%
165,842
+3,399
+2% +$324K
GRMN
528
Garmin
GRMN
$56.7B
$16.4M 0.03%
205,283
+23,533
+13% +$1.93M
EXEL icon
529
Exelixis
EXEL
$13.3B
$16.4M 0.03%
766,558
-29,270
-4% -$613K
CZR
530
DELISTED
Caesars Entertainment Corporation
CZR
$16.3M 0.03%
1,382,833
+4,268
+0.3% +$40.4K
SPOT icon
531
Spotify
SPOT
$103B
$16.3M 0.03%
+111,319
New +$15.3M
CF icon
532
CF Industries
CF
$19.2B
$16.3M 0.03%
348,249
-9,970
-3% -$433K
EME icon
533
Emcor
EME
$35.2B
$16.1M 0.03%
182,993
-198
-0.1% -$16.1K
TPR icon
534
Tapestry
TPR
$30.8B
$16.1M 0.03%
507,749
+1,807
+0.4% +$56.3K
BIO icon
535
Bio-Rad Laboratories Class A
BIO
$8.71B
$16.1M 0.03%
51,532
-214
-0.4% -$64.1K
ALE
536
DELISTED
Allete
ALE
$16.1M 0.03%
193,553
+8,033
+4% +$661K
DECK icon
537
Deckers Outdoor
DECK
$13.2B
$16.1M 0.03%
547,980
+3,804
+0.7% +$98.9K
TAP icon
538
Molson Coors Class B
TAP
$7.79B
$16M 0.03%
285,781
-4,073
-1% -$238K
ETFC
539
DELISTED
E*Trade Financial Corporation
ETFC
$16M 0.03%
357,744
-12,445
-3% -$594K
KSS icon
540
Kohl's
KSS
$2.17B
$15.8M 0.03%
333,303
+35,391
+12% +$2.13M
SABR icon
541
Sabre
SABR
$731M
$15.8M 0.03%
710,793
-29,278
-4% -$628K
WU icon
542
Western Union
WU
$1.99B
$15.7M 0.03%
787,438
-7,344
-0.9% -$143K
CIEN icon
543
Ciena
CIEN
$53.4B
$15.6M 0.03%
380,098
-94,955
-20% -$3.65M
CASY icon
544
Casey's General Stores
CASY
$32.2B
$15.6M 0.03%
100,026
+1,836
+2% +$251K
EXAS
545
DELISTED
Exact Sciences
EXAS
$15.6M 0.03%
131,976
+8,415
+7% +$848K
VSM
546
DELISTED
Versum Materials, Inc.
VSM
$15.6M 0.03%
301,835
+1,460
+0.5% +$75.3K
BMRN icon
547
BioMarin Pharmaceuticals
BMRN
$11.6B
$15.6M 0.03%
181,748
+2,539
+1% +$217K
EGP icon
548
EastGroup Properties
EGP
$11.2B
$15.6M 0.03%
134,217
+15,632
+13% +$1.77M
QRVO icon
549
Qorvo
QRVO
$7.99B
$15.6M 0.03%
233,591
+4,834
+2% +$336K
WSO icon
550
Watsco Inc
WSO
$12.7B
$15.5M 0.03%
95,010
-7,445
-7% -$1.17M

Similar funds

RhumbLine Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, RhumbLine Advisers held 3,102 positions worth $53.3B, up 3.2% from $51.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

RhumbLine Advisers's Q2 2019 filing shows 155 new, 2,027 increased, 775 reduced and 131 closed positions. Its largest new stake was Dow Inc: 1,282,896 shares worth $63.3M. The largest sale was DuPont de Nemours, an estimated $62.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2019 buy was Dow Inc: 1,282,896 shares worth $63.3M.
  • RhumbLine Advisers added most to TCF Financial Corporation Common Stock in Q2 2019, an estimated $19.3M increase.
  • RhumbLine Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $62.6M.
  • RhumbLine Advisers fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $29.7M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $53.3B portfolio in Q2 2019.
  • RhumbLine Advisers opened 155 new positions and closed 131 in Q2 2019.
  • RhumbLine Advisers's portfolio value rose 3.2% quarter-over-quarter to $53.3B.

Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.